: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Diabetes

Free Subscription

Articles published in J Diabetes Complications
Retrieve available abstracts of 362 articles:
HTML format

Single Articles

April 2024

GRACIA-RAMOS AE, Cruz-Dominguez MDP, Madrigal-Santillan EO, Rojas-Martinez R, et al
Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial.
J Diabetes Complications. 2024;38:108742.
PubMed Abstract available

FILARDI T, Feraco A, Ouvrard-Pascaud A, Rizzo M, et al
Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone.
J Diabetes Complications. 2024;38:108741.
PubMed

LASSCHUIT JWJ, Center JR, Greenfield JR, Tonks KTT, et al
Effect of denosumab on inflammation and bone health in active Charcot foot: A phase II randomised controlled trial.
J Diabetes Complications. 2024;38:108718.
PubMed Abstract available

RAKOTOARISOA L, Weiss L, Lefebvre F, Porzio M, et al
Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
J Diabetes Complications. 2024;38:108703.
PubMed Abstract available

March 2024

FARAH R, Alhajahjeh A, Al-Farahid O, Abuzaid H, et al
Risk factors for chronic kidney disease in middle eastern patients with type 2 diabetes mellitus: A cross-sectional study using the KDIGO classification.
J Diabetes Complications. 2024;38:108740.
PubMed Abstract available

FONSECA LM, Kanapka L, Miller K, Pratley R, et al
Risk factors associated with cognitive performance and cognitive impairment in older adults with type 1 diabetes: Data from the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) study.
J Diabetes Complications. 2024;38:108739.
PubMed Abstract available

PINES-CORRALES PJ, Lopez-Garcia MC, Sanz-Velasco A, Moya-Moya AJ, et al
Changes in glucometric parameters in people living with diabetes users of the free-style libre 2 system before and after the update possibility to real-time glucose readings in real world practice.
J Diabetes Complications. 2024;38:108723.
PubMed Abstract available

CAMPOS AC, Lima EG, Jacobsen PK, Arnould L, et al
Association between obstructive coronary disease and diabetic retinopathy: Cross-sectional study of coronary angiotomography and multimodal retinal imaging.
J Diabetes Complications. 2024;38:108721.
PubMed Abstract available

TSUR N, Frankel M, Cahn A, Tsur A, et al
Gestational diabetes and risk of future diabetes in a multi-ethnic population.
J Diabetes Complications. 2024;38:108720.
PubMed Abstract available

VUORLAAKSO M, Karen V, Kiiski J, Lahtela J, et al
Multidisciplinary management of diabetic foot infection associated with improved 8-year overall survival.
J Diabetes Complications. 2024;38:108719.
PubMed Abstract available

February 2024

MATSUURA S, Nagata S, Shibazaki K, Uchida R, et al
Increased skeletal muscle mass index was involved in glycemic efficacy following diabetes treatment, and changes in fat mass index correlated with the changes in the lipid ratio in type 2 diabetes.
J Diabetes Complications. 2024;38:108717.
PubMed Abstract available

KONESHAMOORTHY A, Epa DS, O'Neal DN, Lee MH, et al
Outcomes associated with a variable rate insulin infusion diabetic ketoacidosis protocol.
J Diabetes Complications. 2024;38:108702.
PubMed Abstract available

HSIA DS, Younes N, Krause-Steinrauf H, Kassem LS, et al
The incidence of retinopathy in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness study (GRADE).
J Diabetes Complications. 2024;38:108692.
PubMed Abstract available

RAN GL, Li YP, Lu LC, Lan SH, et al
Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials.
J Diabetes Complications. 2024;38:108691.
PubMed Abstract available

GULLAKSEN S, Vernstrom L, Sorensen SS, Ringgaard S, et al
The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial.
J Diabetes Complications. 2024;38:108673.
PubMed Abstract available

January 2024

RUIZ-MUNOZ M, Martinez-Barrios FJ, Fernandez-Torres R, Lopezosa-Reca E, et al
Autologous platelet-rich plasma (APRP) in diabetes foot disease: a meta-analysis.
J Diabetes Complications. 2024;38:108690.
PubMed Abstract available

ANNUZZI G, Triggiani R, De Angelis R, Rainone C, et al
Delayed prandial insulin boluses are an important determinant of blood glucose control and relate to fear of hypoglycemia in people with type 1 diabetes on advanced technologies.
J Diabetes Complications. 2024;38:108689.
PubMed Abstract available

JIANG M, Yang Z, Lyu L, Shi M, et al
Dapagliflozin attenuates renal fibrosis by suppressing angiotensin II/TGFbeta signaling in diabetic mice.
J Diabetes Complications. 2024;38:108687.
PubMed Abstract available

YAN Q, Li D, Jia S, Yang J, et al
Novel gene-based therapeutic approaches for the management of hepatic complications in diabetes: Reviewing recent advances.
J Diabetes Complications. 2024;38:108688.
PubMed Abstract available

CHUANCHAIYAKUL N, Thongtang N, Rattanaumpawan P
Corrigendum to "Cumulative incidence of and risk factors for herpes zoster among patients with diabetes mellitus: Results from a 10-year nested case-control study" [J Diabetes Complicat., Volume 36, Issue 5, May 2022, 108168].
J Diabetes Complications. 2024;38:108674.
PubMed

LOW S, Ng TP, Goh KS, Moh A, et al
Reduced skeletal muscle mass to visceral fat area ratio is independently associated with reduced cognitive function in type 2 diabetes mellitus.
J Diabetes Complications. 2024;38:108672.
PubMed Abstract available

December 2023

BLAIR YA, Doherty L, Temprosa M, Pop-Busui R, et al
Prevalence and predictors of erectile dysfunction among men in the diabetes prevention program outcomes study.
J Diabetes Complications. 2023;38:108669.
PubMed Abstract available

AU A, Bajar BT, Wong BM, Daskivich LP, et al
Systemic and ocular outcomes in patients with young-onset type 2 diabetes.
J Diabetes Complications. 2023;38:108670.
PubMed Abstract available

ZHANG H, Gu Y, Zhang K, Tu Y, et al
Roles and mechanisms of umbilical cord mesenchymal stem cells in the treatment of diabetic foot: A review of preclinical and clinical studies.
J Diabetes Complications. 2023;38:108671.
PubMed Abstract available

GIANNAKOPOULOS A, Chrysanthakopoulou N, Efthymiadou A, Chrysis D, et al
Diabetic ketosis vs ketoacidosis as initial presentation of pediatric type 1 diabetes mellitus. Associated features and rate of progression during the first two years after diagnosis.
J Diabetes Complications. 2023;38:108667.
PubMed Abstract available

SAHA CK, Shubrook JH, Guyton Hornsby W, Yang Z, et al
Program ACTIVE II: 6- and 12-month outcomes of a treatment approach for major depressive disorder in adults with type 2 diabetes.
J Diabetes Complications. 2023;38:108666.
PubMed Abstract available

KOREI AE, Putz Z, Vagi OE, Tordai DZ, et al
The handgrip test - A historical test for diabetic autonomic neuropathy or a marker of something else?
J Diabetes Complications. 2023;38:108668.
PubMed Abstract available

HANG X, Yu X, Fan S
Lower extremity arterial plaque in patients with type 2 diabetes mellitus: A cross-sectional study of 25-(OH)D(3) and other risk factors.
J Diabetes Complications. 2023;38:108665.
PubMed Abstract available

IDREES T, Umpierrez GE
Beyond pounds: What else could be lost?
J Diabetes Complications. 2023;37:108649.
PubMed

MUZUROVIC E, Yumuk VD, Rizzo M
GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?
J Diabetes Complications. 2023;37:108647.
PubMed

November 2023

ROTBAIN CUROVIC V, Tavenier J, Ferreira-Divino LF, Poulsen CG, et al
Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis.
J Diabetes Complications. 2023;38:108654.
PubMed

DARIO P, Valentina P, Alessandro R, Stefano L, et al
Von Willebrand factor hyperactivity affects the outcome of lower limb revascularization in subjects with type 2 diabetes mellitus complicated by diabetic foot vasculopathy: An observational pilot study.
J Diabetes Complications. 2023;38:108653.
PubMed Abstract available

TANENBAUM ML, Addala A, Hanes S, Ritter V, et al
"It changed everything we do": A mixed methods study of youth and parent experiences with a pilot exercise education intervention following new diagnosis of type 1 diabetes.
J Diabetes Complications. 2023;38:108651.
PubMed Abstract available

WAKAMATSU S, Jojima T, Hashiguchi M, Kishi H, et al
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor.
J Diabetes Complications. 2023;38:108650.
PubMed Abstract available

YANG C, Xiao C, Zhai X, Liu J, et al
SGLT2 inhibitor improves kidney function and morphology by regulating renal metabolism in mice with diabetic kidney disease.
J Diabetes Complications. 2023;38:108652.
PubMed Abstract available

PIRAS DE OLIVEIRA C, Dellva MA, Bue-Valleskey J, Chang AM, et al
Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials.
J Diabetes Complications. 2023;38:108648.
PubMed Abstract available

October 2023

DART AB, Sellers EAC, McGavock J, Del Vecchio M, et al
24-h ambulatory blood pressure readings and associations with albuminuria in youth with type 2 diabetes: A cross sectional analysis from the iCARE cohort.
J Diabetes Complications. 2023;37:108633.
PubMed Abstract available

PAUNICA I, Mihai AD, Stefan S, Pantea-Stoian A, et al
Comparative evaluation of LDL-CT, non-HDL/HDL ratio, and ApoB/ApoA1 in assessing CHD risk among patients with type 2 diabetes mellitus.
J Diabetes Complications. 2023;37:108634.
PubMed Abstract available

BALDIMTSI E, Whiss PA, Wahlberg J
Systemic biomarkers of microvascular alterations in type 1 diabetes associated neuropathy and nephropathy - A prospective long-term follow-up study.
J Diabetes Complications. 2023;37:108635.
PubMed Abstract available

LI M, Liu Z, Yang X, Zhang J, et al
The effect of sodium-glucose cotransporter 2 inhibitors as an adjunct to insulin in patients with type 1 diabetes assessed by continuous glucose monitoring: A systematic review and meta-analysis.
J Diabetes Complications. 2023;37:108632.
PubMed Abstract available

FAUZI A, Thoe ES, Quan TY, Yin ACY, et al
Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus.
J Diabetes Complications. 2023;37:108629.
PubMed Abstract available

XU C, Li H, Xu Q, Zhao K, et al
Dapagliflozin ameliorated retinal vascular permeability in diabetic retinopathy rats by suppressing inflammatory factors.
J Diabetes Complications. 2023;38:108631.
PubMed Abstract available

MOLINUEVO MS, Cortizo AM, Sedlinsky C
Effects of advanced glycation end-products, diabetes and metformin on the osteoblastic transdifferentiation capacity of vascular smooth muscle cells: In vivo and in vitro studies.
J Diabetes Complications. 2023;37:108626.
PubMed Abstract available

SHEN TH, Farley JF
Utilization and impact of SLGT2 inhibitors among diabetes patients in a nationally representative survey: Findings from NHANES 2013-2020.
J Diabetes Complications. 2023;37:108625.
PubMed Abstract available

RITSINGER V, Hagstrom E, Hambraeus K, James S, et al
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial.
J Diabetes Complications. 2023;37:108599.
PubMed Abstract available

SUENAGA A, Sawa N, Oba Y, Ikuma D, et al
Dipeptidyl peptidase-4 inhibitor-related renal disease.
J Diabetes Complications. 2023;37:108590.
PubMed Abstract available

GRIGGS S, Pignatiello G, Motairek I, Rieke J, et al
Environmental exposures and blood pressure in adolescents and adults in the T1D exchange clinic registry.
J Diabetes Complications. 2023;37:108594.
PubMed Abstract available

September 2023

DIAO H, Li X, Xu Y, Xing X, et al
Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus.
J Diabetes Complications. 2023;37:108614.
PubMed Abstract available

LU Y, Zhang Q, Wang X, Jiang Y, et al
Usefulness of glucose management indicator derived from continuous glucose monitoring to assess glycemic condition in hospitalized patients with diabetic kidney disease treated with insulin pumps.
J Diabetes Complications. 2023;37:108613.
PubMed Abstract available

MELING S, Tjora E, Eichele H, Nedergaard RB, et al
Corrigendum to "The PanGut-study: Evoked potentials following rectal balloon distention, a way of evaluating diabetic autonomic neuropathy in the gut?" [J. Diabetes Complicat., Volume 37, Issue 5, May 2023, 108452].
J Diabetes Complications. 2023;37:108612.
PubMed

TOUGAARD NH, Hansen TW, Rossing P
Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: A cohort study.
J Diabetes Complications. 2023;37:108611.
PubMed Abstract available

O CK, Siu BW, Leung VW, Lin YY, et al
Association of insomnia with incident chronic cognitive impairment in older adults with type 2 diabetes mellitus: A prospective study of the Hong Kong Diabetes Register.
J Diabetes Complications. 2023;37:108598.
PubMed Abstract available

MOLITCH ME, Tripputi M, Levey AS, Crandall JP, et al
Effects of metformin and intensive lifestyle interventions on the incidence of kidney disease in adults in the DPP/DPPOS.
J Diabetes Complications. 2023;37:108556.
PubMed Abstract available

ROONEY MR, Daya NR, Leong A, McPhaul MJ, et al
Prognostic value of insulin resistance and hyperglycemia biomarkers for long-term risks of cardiometabolic outcomes.
J Diabetes Complications. 2023;37:108583.
PubMed Abstract available

NAKHLEH A, Goldenberg-Furmanov M, Goldstein R, Shohat M, et al
A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12).
J Diabetes Complications. 2023;37:108566.
PubMed Abstract available

BAK ST, Haupt-Jorgensen M, Dudele A, Wegener G, et al
The anti-inflammatory agent 5-ASA reduces the level of specific tsRNAs in sperm cells of high-fat fed C57BL/6J mouse sires and improves glucose tolerance in female offspring.
J Diabetes Complications. 2023;37:108563.
PubMed Abstract available

SHI M, Zhang H, Wang W, Zhang X, et al
Effect of dapagliflozin on liver and pancreatic fat in patients with type 2 diabetes and non-alcoholic fatty liver disease.
J Diabetes Complications. 2023;37:108610.
PubMed Abstract available

August 2023

LINDEKILDE N, Diaz LJ, Lasgaard M, Henriksen JE, et al
Elevated risk of developing type 2 diabetes in people with a psychiatric disorder: What is the role of health behaviors and psychotropic medication?
J Diabetes Complications. 2023;37:108591.
PubMed Abstract available

HUANG L, Januszewski AS, Takahashi Y, O'Neal DN, et al
Increased intracellular miR-142 in adults with Type 1 diabetes.
J Diabetes Complications. 2023;37:108597.
PubMed Abstract available

PEDERSEN FN, Stokholm L, Andersen N, Andresen J, et al
Longitudinal bidirectional associations between diabetic retinopathy and diagnosed depression: Results from a Danish nationwide registry-based cohort study.
J Diabetes Complications. 2023;37:108589.
PubMed Abstract available

BORDERIE G, Foussard N, Larroumet A, Blanco L, et al
The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: A longitudinal observational study.
J Diabetes Complications. 2023;37:108595.
PubMed Abstract available

KATAOKA Y, Kitahara S, Funabashi S, Makino H, et al
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial.
J Diabetes Complications. 2023;37:108592.
PubMed Abstract available

SKRIVER LKL, Nielsen MW, Walther S, Norlev JD, et al
Factors associated with adherence or nonadherence to insulin therapy among adults with type 2 diabetes mellitus: A scoping review.
J Diabetes Complications. 2023;37:108596.
PubMed Abstract available

YUAN Y, Zhou X, Ji L
Association between remnant cholesterol level and severity of chronic kidney disease in patients with type 2 diabetes.
J Diabetes Complications. 2023;37:108585.
PubMed Abstract available

KRAMER BK, Hauske SJ, Chilton R, Mann JFE, et al
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes.
J Diabetes Complications. 2023;37:108588.
PubMed Abstract available

STAMATI A, Sotiriou G, Dimitriadou M, Christoforidis A, et al
Efficacy and safety of faster aspart in insulin pumps in children and adolescents with type 1 diabetes mellitus: A single-center study with real-world data.
J Diabetes Complications. 2023;37:108587.
PubMed Abstract available

HERMANYI Z, Csiki V, Menyhart A, Osgyan K, et al
How to evaluate over 60 million blood glucose data - The design of the MERY Diabetes Database.
J Diabetes Complications. 2023;37:108586.
PubMed Abstract available

MAINAS G, Nibali L, Rizzo M
Is subclinical cardiovascular disease linked with periodontal disease in diabetic and non-diabetic subjects?
J Diabetes Complications. 2023;37:108580.
PubMed Abstract available

GOMEZ-PERALTA F, Abreu C, Rizzo M
GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms.
J Diabetes Complications. 2023;37:108553.
PubMed

HUANG W, Whitelaw J, Kishore K, Neto AS, et al
The epidemiology of ketosis and low bicarbonate concentration in inpatients treated with sodium-glucose linked cotransporter inhibitors or dipeptidyl peptidase-4 inhibitors.
J Diabetes Complications. 2023;37:108522.
PubMed Abstract available

July 2023

RORTH R, Kriegbaum M, Grand MK, Jacobsen PK, et al
Risk of atrial fibrillation in individuals with dysglycemia and diabetes.
J Diabetes Complications. 2023;37:108579.
PubMed Abstract available

XIAO Q, Wang D, Li D, Huang J, et al
Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes.
J Diabetes Complications. 2023;37:108565.
PubMed Abstract available

FENG RQ, Xu MY, Feng RY, Zhang L, et al
Serum Isthmin-1 is negatively correlated with HDL-C in type 2 diabetes mellitus.
J Diabetes Complications. 2023;37:108567.
PubMed Abstract available

ESMAEILZADEH A, Mohammadi V, Elahi R, Rezakhani N, et al
The role of heat shock proteins (HSPs) in type 2 diabetes mellitus pathophysiology.
J Diabetes Complications. 2023;37:108564.
PubMed Abstract available

STIMSON RH, Dover AR, Strachan MWJ, Wright RJ, et al
Associations between glucagon prescribing, hospital admissions for hypoglycaemia and continuous glucose monitoring metrics in adults with type 1 diabetes.
J Diabetes Complications. 2023;37:108561.
PubMed Abstract available

SCARR D, Lovblom LE, Bjornstad P, Perkins BA, et al
Estimated glomerular filtration rate calculated by serum creatinine lacks precision and accuracy in adults with type 2 diabetes with preserved renal function.
J Diabetes Complications. 2023;37:108562.
PubMed Abstract available

JIN Z, Yuan Y, Zheng C, Liu S, et al
Effects of sodium-glucose co-transporter 2 inhibitors on liver fibrosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: An updated meta-analysis of randomized controlled trials.
J Diabetes Complications. 2023;37:108558.
PubMed Abstract available

CONTRERAS M, Mesa A, Pueyo I, Claro M, et al
Effectiveness of flash glucose monitoring in patients with type 1 diabetes and recurrent hypoglycemia between early and late stages after flash glucose monitoring initiation.
J Diabetes Complications. 2023;37:108560.
PubMed Abstract available

COELHO PM, Simmer LM, da Silva DS, Dos Santos MC, et al
Type 2 diabetes mellitus in obesity promotes prolongation of cardiomyocyte contractile function, impaired Ca(2+) handling and protein carbonylation damage.
J Diabetes Complications. 2023;37:108559.
PubMed Abstract available

GOH YA, Lan NSR, Linn K, Wood C, et al
Comparison of coronary artery calcium score and cardiovascular risk-stratification by European Society of Cardiology Guidelines and Steno Type 1 Risk Engine in statin-naive adults with type 1 diabetes.
J Diabetes Complications. 2023;37:108557.
PubMed Abstract available

GRIFFIN KJ, Rashid TS, Bailey MA, Bird SA, et al
Corrigendum to "Toe amputation: A predictor of future limb loss?" [J. Diabetes Complicat. 26(3) (May-Jun 2012) 251-4].
J Diabetes Complications. 2023 Jul 6:108555. doi: 10.1016/j.jdiacomp.2023.108555
PubMed

KATSIKI N, Rizzo M, Mikhailidis DP
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news!
J Diabetes Complications. 2023;37:108510.
PubMed

June 2023

LIAO M, Chen S, Guo R
Association between carotid ultrasonographic parameters and microvascular and macrovascular complications in diabetes: A systematic review and meta-analysis.
J Diabetes Complications. 2023;37:108554.
PubMed Abstract available

PHAM RT, Pham-Hoang A, Lewis ST, Greenway F, et al
Reversal of diabetic retinopathy in two patients following the use of physiologic insulin Resensitization.
J Diabetes Complications. 2023;37:108549.
PubMed Abstract available

TSUCHIDA K, Soda S, Rizzo M
The legacy effect in early-stage diabetes: Don't stay by me, cardiovascular disease!
J Diabetes Complications. 2023;37:108544.
PubMed

OZTURK NK, Cicek B, Tekin T, Gunturk I, et al
Serum visfatin levels are positively correlated with dietary carbohydrate and polyunsaturated fatty acid intakes in type 2 diabetes mellitus patients.
J Diabetes Complications. 2023;37:108550.
PubMed

OMUR SE, Zorlu C, Acikel B
The effect of dapagliflozin therapy on ventricular repolarization parameters in electrocardiography in patients with diabetic cardiovascular disease.
J Diabetes Complications. 2023;37:108547.
PubMed Abstract available

MOORADIAN AD
Diabetes-related perturbations in the integrity of physiologic barriers.
J Diabetes Complications. 2023;37:108552.
PubMed Abstract available

ALMEIDA EA, Mehndiratta M, Madhu SV, Kar R, et al
PINK1 and oxidative stress in lean and obese patients with type 2 diabetes mellitus.
J Diabetes Complications. 2023;37:108542.
PubMed Abstract available

PRAMODKUMAR TA, Sivaprasad S, Venkatesan U, Mohan V, et al
Role of cystatin C in the detection of sight-threatening diabetic retinopathy in Asian Indians with type 2 diabetes.
J Diabetes Complications. 2023;37:108545.
PubMed Abstract available

WILLIAMSON T, Gomez-Espinosa E, Stewart F, Dean BB, et al
Poor adherence to clinical practice guidelines: A call to action for increased albuminuria testing in patients with type 2 diabetes.
J Diabetes Complications. 2023;37:108548.
PubMed Abstract available

BANERJEE Y, Patti AM, Giglio RV, Ciaccio M, et al
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance.
J Diabetes Complications. 2023;37:108517.
PubMed Abstract available

GRUBIC ROTKVIC P, Celap I, Bralic Lang V, Jug J, et al
Impact of SGLT2 inhibitors on the mechanisms of myocardial dysfunction in type 2 diabetes: A prospective non-randomized observational study in patients with type 2 diabetes mellitus without overt heart disease.
J Diabetes Complications. 2023;37:108541.
PubMed Abstract available

HERMAN WH, Villatoro C, Joiner KL, McEwen LN, et al
Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience.
J Diabetes Complications. 2023;37:108527.
PubMed Abstract available

PATOULIAS D, Popovic DS, Stoian AP, Janez A, et al
Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials.
J Diabetes Complications. 2023;37:108529.
PubMed Abstract available

FOGACCI F, Rizzo M, Cicero AFG
PUFA treatment in patients with gestational diabetes mellitus: Lights and shadows.
J Diabetes Complications. 2023;37:108526.
PubMed

GUPTA A, Jeyaprakash P, Ghoreyshi-Hefzabad SM, Pathan F, et al
Left ventricular longitudinal systolic dysfunction in children with type 1 diabetes mellitus: A systematic review and meta-analysis.
J Diabetes Complications. 2023;37:108528.
PubMed Abstract available

SIWAN E, Parry SN, Williams KH, McGill MJ, et al
Circulating soluble CD163 as a potential biomarker of diabetes complications.
J Diabetes Complications. 2023;37:108525.
PubMed Abstract available

WU L, Zhao YY, Li MR, Chang DY, et al
Clinical and pathological characteristics of DKD patients with early-onset type 2 diabetes.
J Diabetes Complications. 2023;37:108520.
PubMed Abstract available

CHENG Y, Wang H, Li M
The promise of CRISPR/Cas9 technology in diabetes mellitus therapy: How gene editing is revolutionizing diabetes research and treatment.
J Diabetes Complications. 2023;37:108524.
PubMed Abstract available

DZHUN Y, Mankovsky G, Rudenko N, Marushko Y, et al
Glycemic variability is associated with diastolic dysfunction in patients with type 2 diabetes.
J Diabetes Complications. 2023;37:108519.
PubMed Abstract available

CAI Z, Hu X, Gui L, Qi M, et al
Study on the therapeutic effect and mechanism of Tangningtongluo Tablet on diabetic mice.
J Diabetes Complications. 2023;37:108523.
PubMed Abstract available

May 2023

LIN H, Zhu J, Zheng C, Xu X, et al
The correlation between visceral fat/subcutaneous fat area ratio and monocyte/high-density lipoprotein ratio in patients with type 2 diabetes mellitus and albuminuria.
J Diabetes Complications. 2023;37:108521.
PubMed Abstract available

HUHTALA MS, Ronnemaa T, Paavilainen E, Niinikoski H, et al
Prediction of pre-diabetes and type 2 diabetes nine years postpartum using serum metabolome in pregnant women with gestational diabetes requiring pharmacological treatment.
J Diabetes Complications. 2023;37:108513.
PubMed Abstract available

LUO J, Tao Y, Xu Y, Yang L, et al
Global comparison of the effect of non-pharmacological interventions on glycemic control in patients with type 2 diabetes: A network meta-analysis from 107 randomized controlled trials.
J Diabetes Complications. 2023;37:108518.
PubMed Abstract available

ADDALA A, Wong JJ, Penaranda RM, Hanes SJ, et al
Expanding the use of patient-reported outcomes (PROs): Screening youth with type 1 diabetes from underrepresented populations.
J Diabetes Complications. 2023;37:108514.
PubMed Abstract available

RASTOGI A, Weir MR
Multimodal efforts to slow the progression of chronic kidney disease in patients with type 2 diabetes mellitus.
J Diabetes Complications. 2023;37:108515.
PubMed Abstract available

DEROSA G, Rizzo M, Brunetti ND, Raddino R, et al
ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON).
J Diabetes Complications. 2023;37:108512.
PubMed Abstract available

IZADI R, Hejazi SH, Bahramikia S
Injection of stem cells derived from allogeneic adipose tissue, a new strategy for the treatment of diabetic wounds.
J Diabetes Complications. 2023;37:108496.
PubMed Abstract available

SONG XT, Wei YL, Rui YF, Fan L, et al
Echocardiographic evaluation of the effect of dapagliflozin on epicardial adipose tissue and left ventricular systolic function in type 2 diabetes mellitus.
J Diabetes Complications. 2023;37:108509.
PubMed Abstract available

MANICA D, Sandri G, da Silva GB, Manica A, et al
Evaluation of the effects of metformin on antioxidant biomarkers and mineral levels in patients with type II diabetes mellitus: A cross-sectional study.
J Diabetes Complications. 2023;37:108497.
PubMed Abstract available

BAILEY RJ, Sarkar A, Snell-Bergeon JK, Burkhardt BR, et al
Periodontitis and cardiovascular risk factors in subjects with and without type 1 diabetes: A cross sectional analysis.
J Diabetes Complications. 2023;37:108494.
PubMed Abstract available

VERDECIAS N, McQueen A, Von Nordheim DA, Broussard DJ Jr, et al
Diabetes distress in a Medicaid sample: The role of psychosocial and health-related factors.
J Diabetes Complications. 2023;37:108495.
PubMed Abstract available

FORD JH, Lage MJ, Boye KS, Bae JP, et al
Five-year morbidity and mortality rates in a U.S. population with obesity with and without prediabetes.
J Diabetes Complications. 2023;37:108454.
PubMed Abstract available

XIE Q, Ma L, Xiao Z, Yang M, et al
Role of profilin-1 in vasculopathy induced by advanced glycation end products (AGEs).
J Diabetes Complications. 2023;37:108415.
PubMed Abstract available

April 2023

TZOGIOU C, Wieser S, Eichler K, Carlander M, et al
Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland: A health-economic analysis.
J Diabetes Complications. 2023;37:108476.
PubMed Abstract available

LAURSEN JC, Hansen CS, Bordino M, Frimodt-Moller M, et al
The association between blood oxygen saturation and baroreflex sensitivity in adults with type 1 diabetes with and without albuminuria.
J Diabetes Complications. 2023;37:108473.
PubMed Abstract available

XU J, Lv H
PSTPIP2 alleviates obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through promoting M2 macrophage polarization via activation of PPARgamma.
J Diabetes Complications. 2023;37:108479.
PubMed Abstract available

LI H, Li M, Dong S, Dong A, et al
Preliminary study of the interactive effects of coronary heart disease and lacunar infarction on renal function in patients with type 2 diabetes mellitus by gender.
J Diabetes Complications. 2023;37:108477.
PubMed Abstract available

ZHANG C, Lin W, Xu Q, Li H, et al
Association between high-density lipoprotein cholesterol to apolipoprotein A ratio and diabetic retinopathy: A cross-sectional study.
J Diabetes Complications. 2023;37:108471.
PubMed Abstract available

FARAH R, Alhajahjeh A, Nofal A, Hyasat TB, et al
Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study.
J Diabetes Complications. 2023;37:108478.
PubMed Abstract available

RUAN Y, Mercuri L, Papadimitriou D, Galdikas A, et al
Increase in hypoglycaemia and hyperglycaemia in people with diabetes admitted to hospital during COVID-19 pandemic.
J Diabetes Complications. 2023;37:108474.
PubMed Abstract available

CORBIN KD, Pittas AG, Desouza C, Grdinovac KK, et al
Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study.
J Diabetes Complications. 2023;37:108475.
PubMed Abstract available

GULLAKSEN S, Vernstrom L, Sorensen SS, Funck KL, et al
Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised clinical trial.
J Diabetes Complications. 2023;37:108472.
PubMed Abstract available

ADIE SK, Ketcham SW, Marshall VD, Farina N, et al
The association of glucose control on in-hospital mortality in the cardiac intensive care unit.
J Diabetes Complications. 2023;37:108453.
PubMed Abstract available

LIN Y, Shao H, Fonseca V, Anderson AH, et al
A prediction model on incident ESKD among individuals with T2D and CKD.
J Diabetes Complications. 2023;37:108450.
PubMed Abstract available

DESAI NR, Navaneethan SD, Nicholas SB, Pantalone KM, et al
Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice.
J Diabetes Complications. 2023;37:108411.
PubMed Abstract available

BECHLIOULIS A, Markozannes G, Chionidi I, Liberopoulos E, et al
The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study.
J Diabetes Complications. 2023;37:108436.
PubMed Abstract available

March 2023

HAYASHI A, Shimizu N, Suzuki A, Fujishima R, et al
Novel clinical associations between time in range and microangiopathies in people with type 2 diabetes mellitus on hemodialysis.
J Diabetes Complications. 2023;37:108470.
PubMed Abstract available

KATAOKA Y, Yasuda S, Asaumi Y, Honda S, et al
Long-term effects of lowering postprandial glucose level on cardiovascular outcomes in early-stage diabetic patients with coronary artery disease: 10-year post-trial follow-up analysis of the DIANA study.
J Diabetes Complications. 2023;37:108469.
PubMed Abstract available

HU WS, Lin CL
Patients with diabetes with and without sodium-glucose cotransporter-2 inhibitors use with incident cancer risk.
J Diabetes Complications. 2023;37:108468.
PubMed Abstract available

WOODHAMS LM, Chalmers L, Sim TF, Yeap BB, et al
Efficacy and safety of sodium glucose cotransporter 2 inhibitors plus standard care in diabetic kidney disease: A systematic review and meta-analysis.
J Diabetes Complications. 2023;37:108456.
PubMed Abstract available

CIFUENTES-MENDIOLA SE, Solis-Suarez DL, Martinez-Davalos A, Garcia-Hernandez AL, et al
Macrovascular and microvascular type 2 diabetes complications are interrelated in a mouse model.
J Diabetes Complications. 2023;37:108455.
PubMed Abstract available

MELING S, Tjora E, Eichele H, Nedergaard RB, et al
The PanGut-study: Evoked potentials following rectal balloon distention, a way of evaluating diabetic autonomic neuropathy in the gut?
J Diabetes Complications. 2023;37:108452.
PubMed Abstract available

LIU W, Gao M, Yang S, Sun C, et al
Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
J Diabetes Complications. 2023;37:108451.
PubMed Abstract available

February 2023

GUO J, Jiang G, Chen J, Zhang M, et al
Tumor tissue derived extracellular vesicles promote diabetic wound healing.
J Diabetes Complications. 2023;37:108435.
PubMed Abstract available

ROTBAIN CUROVIC V, Tofte N, Lindhardt M, Adamova K, et al
Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trial.
J Diabetes Complications. 2023;37:108433.
PubMed Abstract available

PANTALONE KM, Ji X, Kong SX, Elliott JC, et al
Unmet needs and opportunities for optimal management of patients with type 2 diabetes and chronic kidney disease.
J Diabetes Complications. 2023;37:108418.
PubMed Abstract available

TESFAYE S, Brill S, Eerdekens M, Labrador MM, et al
Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries.
J Diabetes Complications. 2023;37:108417.
PubMed Abstract available

XIANG X, Huang X, Zhang Z, Gu J, et al
Dysregulation of circulating CD4 + CXCR5 + PD-1+ T cells in diabetic retinopathy.
J Diabetes Complications. 2023;37:108420.
PubMed Abstract available

LIN Y, Shao H, Fonseca V, Anderson AH, et al
A prediction model of CKD progression among individuals with type 2 diabetes in the United States.
J Diabetes Complications. 2023;37:108413.
PubMed Abstract available

VEKIC J, Stoian AP, Rizzo M
Lipoprotein subclasses and early kidney dysfunction in young type 1 diabetes mellitus patients.
J Diabetes Complications. 2023;37:108412.
PubMed

ZHANG Y, Zhang Q, Bai Y, Zheng H, et al
Glycogen synthesis kinase-3beta involves in the analgesic effect of liraglutide on diabetic neuropathic pain.
J Diabetes Complications. 2023;37:108416.
PubMed Abstract available

ABO EL-ASRAR M, Ismail EAR, Elnhrawy AM, Thabet RA, et al
Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes.
J Diabetes Complications. 2023;37:108414.
PubMed Abstract available

PEDROSA AR, Martins DC, Rizzo M, Silva-Nunes J, et al
Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.
J Diabetes Complications. 2023;37:108391.
PubMed Abstract available

January 2023

BLANCHETTE V, Armstrong DG, Drudi L, Rizzo M, et al
Upstream comprehensive management of individuals with diabetes with multimorbidity and frailty to act against amputation.
J Diabetes Complications. 2023;37:108407.
PubMed Abstract available

FENG B, Yang F, Liu J, Sun Q, et al
Amelioration of diabetic kidney injury with dapagliflozin is associated with suppressing renal HMGB1 expression and restoring autophagy in obese mice.
J Diabetes Complications. 2023;37:108409.
PubMed Abstract available

CERIELLO A, Lalic N, Montanya E, Valensi P, et al
NT-proBNP point-of-care measurement as a screening tool for heart failure and CVD risk in type 2 diabetes with hypertension.
J Diabetes Complications. 2023;37:108410.
PubMed Abstract available

WIRKKALA J, Kubin AM, Ohtonen P, Falck A, et al
Outcomes of 35-year duration of type 1 diabetes and proliferative diabetic retinopathy on functional vision and quality of life: Benefits of good glycemic control.
J Diabetes Complications. 2023;37:108408.
PubMed Abstract available

CHEN Y, Wang Y, Zhang Y, Li M, et al
Association of peripheral neuropathy with subclinical left ventricular dysfunction in patients with type 2 diabetes.
J Diabetes Complications. 2023;37:108406.
PubMed Abstract available

LUNDHOLM MD, Bena J, Zhou K, Tsushima Y, et al
Prevalence and clinical determinants of non-alcoholic fatty liver disease by liver scores in adults with type 1 diabetes.
J Diabetes Complications. 2023;37:108405.
PubMed Abstract available

BORDERIE G, Foussard N, Larroumet A, Blanco L, et al
Albuminuric diabetic kidney disease predicts foot ulcers in type 2 diabetes.
J Diabetes Complications. 2023;37:108403.
PubMed Abstract available

HANDELSMAN Y, Butler J, Bakris GL, DeFronzo RA, et al
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases.
J Diabetes Complications. 2023;37:108389.
PubMed Abstract available

PORADZKA AA, Czupryniak L
The use of the artificial neural network for three-month prognosis in diabetic foot syndrome.
J Diabetes Complications. 2023;37:108392.
PubMed

PINTO C, Sa JR, Lana J, Dualib P, et al
Association of parental cardiovascular risk factors with offspring type 1 diabetes mellitus insulin sensitivity.
J Diabetes Complications. 2023;37:108393.
PubMed Abstract available

December 2022

LIARAKOS AL, Tentolouris A, Kokkinos A, Eleftheriadou I, et al
Impact of Glucagon-like peptide 1 receptor agonists on peripheral arterial disease in people with diabetes mellitus: A narrative review.
J Diabetes Complications. 2022;37:108390.
PubMed Abstract available

ASLANI S, Jensen CW, Olsson AO, Thomsen SS, et al
Time in range is associated with less hypoglycemia fear and higher diabetes technology acceptance in adults with well-controlled T1D.
J Diabetes Complications. 2022;37:108388.
PubMed

BARRERA ECHEGOYEN FX, Szeto A, Mendez AJ, Garg R, et al
The nature and characteristics of hypertriglyceridemia in a large cohort with type 2 diabetes.
J Diabetes Complications. 2022;37:108387.
PubMed Abstract available

ORIOT P, Hermans MP
Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
J Diabetes Complications. 2022;37:108385.
PubMed Abstract available

TORM MEW, Dorweiler TF, Fickweiler W, Levine SR, et al
Frontiers in diabetic retinal disease.
J Diabetes Complications. 2022;37:108386.
PubMed Abstract available

WANG A, Zhang S, Li Y, Zhu F, et al
Study on the relationship between lipoprotein (a) and diabetic kidney disease.
J Diabetes Complications. 2022;37:108378.
PubMed Abstract available

PAULEY ME, Vinovskis C, MacDonald A, Baca M, et al
Triglyceride content of lipoprotein subclasses and kidney hemodynamic function and injury in adolescents with type 1 diabetes.
J Diabetes Complications. 2022;37:108384.
PubMed Abstract available

XIA C, Suriyanarayanan S, Gong Y, Fridman V, et al
Long-term effects of l-serine supplementation upon a mouse model of diabetic neuropathy.
J Diabetes Complications. 2022;37:108383.
PubMed Abstract available

LI X, Kong X, Li R
Correlation between lipoprotein(a), albuminuria, myostatin and sarcopenia in elderly patients with type 2 diabetes.
J Diabetes Complications. 2022;37:108382.
PubMed Abstract available

VUORLAAKSO M, Kiiski J, Majava M, Helminen M, et al
Retrospective cohort study of long-term outcomes and prognostic factors for survival after lower extremity amputation in patients with diabetes.
J Diabetes Complications. 2022;37:108377.
PubMed Abstract available

LI H, Zhang J, Guo Q, Xie W, et al
Associations among carotid plaque progression, cerebrovascular/cardiovascular diseases and LDL-C/non-HDL-C goal achievement in diabetic patients: A retrospective cohort study.
J Diabetes Complications. 2022;37:108381.
PubMed Abstract available

ALEXOPOULOS AS, Soliman D, Lewinski AA, Strawbridge E, et al
Simplifying therapy to assure glycemic control and engagement (STAGE) in poorly-controlled diabetes: A pilot study.
J Diabetes Complications. 2022;37:108364.
PubMed Abstract available

XU Y, Hou H, Zhao L
The role of VCAM-1 in diabetic retinopathy: A systematic review and meta-analysis.
J Diabetes Complications. 2022;37:108380.
PubMed Abstract available

KANIA M, Sudul P, Mazur K, Chaykivska Z, et al
Type 1 diabetes outpatient care and treatment effectiveness during COVID-19: A single-center cohort study.
J Diabetes Complications. 2022;37:108379.
PubMed Abstract available

TALL BULL S, Nuffer W, Trujillo JM
Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist.
J Diabetes Complications. 2022;36:108332.
PubMed Abstract available

November 2022

GONG M, Xu M, Meng J, Jiang S, et al
Diabetic microvascular complications are associated with left atrial structural alterations in asymptomatic type 2 diabetes patients: A cross-sectional study.
J Diabetes Complications. 2022;37:108361.
PubMed Abstract available

DOTZERT MS, McDonald MW, Olver TD, Sammut MJ, et al
The influence of exercise training versus intensive insulin therapy on insulin resistance development in type 1 diabetes.
J Diabetes Complications. 2022;37:108365.
PubMed Abstract available

LI J, Ji C, Zhang W, Lan L, et al
Effect of new glucose-lowering drugs on stroke in patients with type 2 diabetes: A systematic review and Meta-analysis.
J Diabetes Complications. 2022;37:108362.
PubMed Abstract available

PAPACHRISTOFOROU E, Liatis S, Psoma O, Kountouri A, et al
Effect of the first and second COVID-19 associated lockdown on the metabolic control of patients with type 2 diabetes in Greece.
J Diabetes Complications. 2022;37:108363.
PubMed Abstract available

MUZUROVIC E, Rizzo M, Mikhailidis DP
Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients.
J Diabetes Complications. 2022;36:108359.
PubMed

ZHENG X, Jiang M, Ren X, Han L, et al
The longitudinal association of remnant cholesterol with diabetes in middle-aged and elderly Chinese: A nationwide population-based cohort study.
J Diabetes Complications. 2022;37:108360.
PubMed Abstract available

LIMONTE CP, Kretzler M, Pennathur S, Pop-Busui R, et al
Present and future directions in diabetic kidney disease.
J Diabetes Complications. 2022;36:108357.
PubMed Abstract available

DEMIRER B, Yardimci H, Erem Basmaz S
Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: A pathway analysis.
J Diabetes Complications. 2022;37:108354.
PubMed Abstract available

OLESEN K, Willaing I, Maindal HT, Andersen GS, et al
Does health literacy predict cardiometabolic marker trajectories among people with diabetes? A longitudinal mixed-effect analysis.
J Diabetes Complications. 2022;37:108358.
PubMed Abstract available

PAPACHRISTOU S, Pafili K, Trypsianis G, Papazoglou D, et al
Skin advanced glycation end products as a screening tool of neuropathy in type 2 diabetes mellitus.
J Diabetes Complications. 2022;36:108356.
PubMed Abstract available

CLEMENTS JM
Access to care by Medicare beneficiaries in the U.S. with diabetes and multiple chronic conditions during the COVID-19 pandemic.
J Diabetes Complications. 2022;36:108355.
PubMed Abstract available

MIZRAK HI, Hansen TW, Andersen JA, Rossing P, et al
Distal symmetrical polyneuropathy is present in all individuals with diabetes and foot ulcers - and does not associate with healing time.
J Diabetes Complications. 2022;36:108353.
PubMed Abstract available

WU J, Zhao X, Chen H, Zhu S, et al
Metabolic effects of the dual SGLT 1/2 inhibitor sotagliflozin on blood pressure and body weight reduction in people with diabetes: An updated meta-analysis of randomized controlled trials.
J Diabetes Complications. 2022;36:108352.
PubMed Abstract available

VINODHINI S, Sengani M, Choudhury AA, Ramasubbu K, et al
Regulation of glucose transporter-4 intervention with S. saman leaves extract in streptozotocin-induced diabetic rats.
J Diabetes Complications. 2022;36:108340.
PubMed Abstract available

JENSTERLE M, Rizzo M, Janez A
Weight response to GLP-1 receptor agonists: Why women do it better?
J Diabetes Complications. 2022;36:108310.
PubMed

October 2022

TAS E, Bai S, Mak D, Diaz EC, et al
Obesity, but not glycemic control, predicts liver steatosis in children with type 1 diabetes.
J Diabetes Complications. 2022;36:108341.
PubMed Abstract available

LUTSKI M, Weinstein G, Goldbourt U, Tanne D, et al
Peripheral sensory nerve function, type 2 diabetes and frailty among men with cardiovascular disease.
J Diabetes Complications. 2022;36:108337.
PubMed Abstract available

TAN SW, Xie T, Malik TH, Gao Y, et al
Advances of neurovascular protective potential of 3-N-butylphthalide and its derivatives in diabetic related diseases.
J Diabetes Complications. 2022;36:108335.
PubMed Abstract available

POPOVIC DS, Stoian AP, Papanas N
Could cardiorenal benefits of sodium-glucose co-transporter 2 inhibitors be extended to type 1 diabetes mellitus?
J Diabetes Complications. 2022;36:108338.
PubMed

ANG L, Mizokami-Stout K, Eid SA, Elafros M, et al
The conundrum of diabetic neuropathies-Past, present, and future.
J Diabetes Complications. 2022;36:108334.
PubMed Abstract available

RIZVI AA, Kathuria A, Al Mahmeed W, Al-Rasadi K, et al
Post-COVID syndrome, inflammation, and diabetes.
J Diabetes Complications. 2022;36:108336.
PubMed Abstract available

SU EJ, Lawrence DA
Diabetes and the treatment of ischemic stroke.
J Diabetes Complications. 2022;36:108318.
PubMed Abstract available

SAVELIEFF MG, Chen KS, Elzinga SE, Feldman EL, et al
Diabetes and dementia: Clinical perspective, innovation, knowledge gaps.
J Diabetes Complications. 2022;36:108333.
PubMed Abstract available

SHAO H, Shi L, Lin Y, Fonseca V, et al
Using modern risk engines and machine learning/artificial intelligence to predict diabetes complications: A focus on the BRAVO model.
J Diabetes Complications. 2022;36:108316.
PubMed Abstract available

September 2022

SCHMIDT BM, Holmes CM, Najarian K, Gallagher K, et al
On diabetic foot ulcer knowledge gaps, innovation, evaluation, prediction markers, and clinical needs.
J Diabetes Complications. 2022;36:108317.
PubMed Abstract available

LYTVYN Y, Albakr R, Bjornstad P, Lovblom LE, et al
Renal hemodynamic dysfunction and neuropathy in longstanding type 1 diabetes: Results from the Canadian study of longevity in type 1 diabetes.
J Diabetes Complications. 2022;36:108320.
PubMed Abstract available

GAO Y, Zhou M, Xu X, Chen WY, et al
Effects of flash glucose monitoring on glycemic control in participants with diabetes mellitus: A meta-analysis of randomized controlled trials.
J Diabetes Complications. 2022;36:108314.
PubMed Abstract available

SAITO I, Maruyama K, Kato T, Takata Y, et al
Role of insulin resistance in the association between resting heart rate and type 2 diabetes: A prospective study.
J Diabetes Complications. 2022;36:108319.
PubMed Abstract available

IIDA T, Hosojima M, Kabasawa H, Yamamoto-Kabasawa K, et al
Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study.
J Diabetes Complications. 2022;36:108312.
PubMed Abstract available

IQBAL A, Tekin Z, Kattan MW, Ji X, et al
Association between first-line monotherapy with metformin and the risk of atrial fibrillation (AMRAF) in patients with type 2 diabetes.
J Diabetes Complications. 2022;36:108315.
PubMed Abstract available

YANG H, Xia M, Liu Z, Xing Y, et al
Nomogram for prediction of diabetic retinopathy in patients with type 2 diabetes mellitus: A retrospective study.
J Diabetes Complications. 2022;36:108313.
PubMed Abstract available

SAEI GHARE NAZ M, Sheidaei A, Azizi F, Ramezani Tehrani F, et al
Gestational diabetes mellitus and hypertensive disorder of pregnancy play as spouse-pair risk factors of diabetes and hypertension: Insights from Tehran Lipid and Glucose Study.
J Diabetes Complications. 2022;36:108311.
PubMed Abstract available

TINSLEY JP, Carpenter RD, Pyle LL, Snell-Bergeon JK, et al
Femoral neck structural properties are altered in adults with type 1 diabetes.
J Diabetes Complications. 2022;36:108308.
PubMed Abstract available

SHAIKH K, Ahmed A, Gransar H, Lee J, et al
Extent of subclinical atherosclerosis on coronary computed tomography and impact of statins in patients with diabetes without known coronary artery disease: Results from CONFIRM registry.
J Diabetes Complications. 2022;36:108309.
PubMed Abstract available

CHIANG HH, Surampudi P, Sood A
Determinants of initial insulin therapy for hospitalized patients with diabetes mellitus.
J Diabetes Complications. 2022;36:108307.
PubMed Abstract available

KHAN SA, Shields S, Abusamaan MS, Mathioudakis N, et al
Association between dysglycemia and the Charlson Comorbidity Index among hospitalized patients with diabetes.
J Diabetes Complications. 2022;36:108305.
PubMed Abstract available

LIAO KM, Wang SH, Tsai LT, Chen YC, et al
A non-invasive harmonic analysis to assess risk of retinopathy in type 2 diabetes mellitus.
J Diabetes Complications. 2022;36:108306.
PubMed Abstract available

CHIKOTI S, Najiya U, Sumanlatha G, Jahan P, et al
Cytokine gene variants of TNF-alpha and IL-10 in the propensity of type 2 diabetes in south Indian population.
J Diabetes Complications. 2022;36:108304.
PubMed Abstract available

August 2022

ZHANG Y, Yin Y, Zhang X, Ye J, et al
Association of adverse childhood experiences with diabetes: A systematic review and meta-analysis.
J Diabetes Complications. 2022;36:108289.
PubMed Abstract available

VERHAGEN C, Janssen J, Minderhoud CA, van den Berg E, et al
Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk.
J Diabetes Complications. 2022;36:108303.
PubMed Abstract available

BLAIR Y, Wessells H, Pop-Busui R, Ang L, et al
Urologic complications in diabetes.
J Diabetes Complications. 2022;36:108288.
PubMed Abstract available

KIANMEHR H, Guo J, Lin Y, Luo J, et al
A machine learning approach identifies modulators of heart failure hospitalization prevention among patients with type 2 diabetes: A revisit to the ACCORD trial.
J Diabetes Complications. 2022;36:108287.
PubMed Abstract available

PAPPA E, Kostara C, Bairaktari E, Arvaniti E, et al
Effect of fixed-dose combination of insulin degludec and liraglutide on apoB-containing lipoprotein subclasses and HDL lipidome in type 2 diabetes.
J Diabetes Complications. 2022;36:108286.
PubMed Abstract available

GOLDENBERG RM
Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis.
J Diabetes Complications. 2022;36:108285.
PubMed

MAHGOUB U, Magee MJ, Heydari M, Choudhary M, et al
Outpatient clinic attendance and outcomes among patients hospitalized with diabetic foot ulcers.
J Diabetes Complications. 2022;36:108283.
PubMed Abstract available

CUI Y, Marshall A, Tsaih SW, Palatnik A, et al
Impact of prior gestational diabetes on long-term type 2 diabetes complications.
J Diabetes Complications. 2022;36:108282.
PubMed Abstract available

DESOUZA C, Chatterjee R, Vickery EM, Nelson J, et al
The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study.
J Diabetes Complications. 2022;36:108230.
PubMed Abstract available

July 2022

HJORTKJAER HO, Persson F, Theilade S, Winther SA, et al
Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes.
J Diabetes Complications. 2022;36:108270.
PubMed Abstract available

AL-KINDI S, Dong T, Chen W, Tashtish N, et al
Relation of coronary calcium scoring with cardiovascular events in patients with diabetes: The CLARIFY Registry.
J Diabetes Complications. 2022;36:108269.
PubMed Abstract available

ESPELAND MA, Howard M, Bennett W, Robusto BA, et al
Associations between cognitive function and endogenous levels of estradiol and testosterone in adults with type 2 diabetes.
J Diabetes Complications. 2022;36:108268.
PubMed Abstract available

LEVITSKY LL, Drews KL, Haymond M, Glubitosi-Klug RA, et al
The obesity paradox: Retinopathy, obesity, and circulating risk markers in youth with type 2 diabetes in the TODAY Study.
J Diabetes Complications. 2022;36:108259.
PubMed Abstract available

LOW S, Goh KS, Ng TP, Moh A, et al
Decline in skeletal muscle mass is associated with cognitive decline in type 2 diabetes mellitus.
J Diabetes Complications. 2022;36:108258.
PubMed Abstract available

TIAN L, Yang YM, Zhu J, Zhang H, et al
Gender difference in association between diabetes mellitus and all-cause mortality in atrial fibrillation patients.
J Diabetes Complications. 2022;36:108265.
PubMed Abstract available

MUTHULINGAM JA, Brock C, Hansen TM, Drewes AM, et al
Disrupted white matter integrity in the brain of type 1 diabetes is associated with peripheral neuropathy and abnormal brain metabolites.
J Diabetes Complications. 2022;36:108267.
PubMed Abstract available

WIUM-ANDERSEN IK, Jorgensen TSH, Jorgensen MB, Osler M, et al
Diabetes, sleep disorders and risk of depression - A Danish register-based cohort study.
J Diabetes Complications. 2022;36:108266.
PubMed Abstract available

LIN KD, Chang LH, Wu YR, Hsu WH, et al
Association of depression and parasympathetic activation with glycemic control in type 2 diabetes mellitus.
J Diabetes Complications. 2022 Jul 12:108264.
PubMed Abstract available

MARK EB, Liao D, Nedergaard RB, Hansen TM, et al
Central neuronal transmission in response to tonic cold pain is modulated in people with type 1 diabetes and severe polyneuropathy.
J Diabetes Complications. 2022 Jul 12:108263.
PubMed Abstract available

GRASSI BA, Carames B, Plaza-Plaza JC, Onetto MT, et al
Insulin settings and their association with time in range in patients with type 1 diabetes users of predictive low glucose suspend (PLGS) augmented insulin pumps in Santiago, Chile.
J Diabetes Complications. 2022 Jul 11:108262.
PubMed Abstract available

HEUBEL AD, Kabbach EZ, Migliato GR, Russo MIS, et al
Role of arterial stiffness and endothelial dysfunction on lower limb performance in older adults with type 2 diabetes: A cross-sectional study.
J Diabetes Complications. 2022 Jul 10:108260.
PubMed Abstract available

STOUGAARD EB, Rossing P, Cherney D, Vistisen D, et al
Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines.
J Diabetes Complications. 2022 Jul 9:108257. doi: 10.1016/j.jdiacomp.2022.108257
PubMed Abstract available

YOSHIDA Y, Joshi P, Barri S, Wang J, et al
Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis.
J Diabetes Complications. 2022 Jul 5:108255. doi: 10.1016/j.jdiacomp.2022.108255
PubMed Abstract available

FISHER L, Polonsky WH, Perez-Nieves M, Desai U, et al
A new perspective on diabetes distress using the type 2 diabetes distress assessment system (T2-DDAS): Prevalence and change over time.
J Diabetes Complications. 2022 Jul 5:108256. doi: 10.1016/j.jdiacomp.2022.108256
PubMed Abstract available

BARZILAY JI, Younes N, Pop-Busui R, Florez H, et al
Corrigendum to "The cross-sectional association of renal dysfunction with tests of cognition in middle-aged adults with early type 2 diabetes The GRADE Study" [J. Diabetes Complicat., 35 (3) (2021) 107805].
J Diabetes Complications. 2022 Jul 5:108254. doi: 10.1016/j.jdiacomp.2022.108254
PubMed

CHOI D, Gujral UP, Patel SA
Mortality differentials by previous diagnosis of diabetes and glycemic status in the United States.
J Diabetes Complications. 2022;36:108250.
PubMed Abstract available

HEMPE JM, Hsia DS
Variation in the hemoglobin glycation index.
J Diabetes Complications. 2022;36:108223.
PubMed Abstract available

June 2022

KANAZAWA K, Suzuki S, Koga S, Kuwabara K, et al
A comprehensive risk assessment for nocturnal hypoglycemia in geriatric patients with type 2 diabetes: A single-center case-control study.
J Diabetes Complications. 2022 Jun 28:108239.
PubMed Abstract available

DE LOS A JIMENEZ PRIETO P, Alvarez Banuelos MT, Romero JM, Cordoba BC, et al
Influence of type 2 diabetes mellitus on mortality in women with breast cancer: A matched case-control study.
J Diabetes Complications. 2022 Jun 28:108249.
PubMed Abstract available

SOW MA, Magne J, Salle L, Nobecourt E, et al
Prevalence, determinants and prognostic value of high coronary artery calcium score in asymptomatic patients with diabetes: A systematic review and meta-analysis.
J Diabetes Complications. 2022 Jun 26:108237.
PubMed

HU B, Zhang L, Zhao ZS, Qi YC, et al
The predictive value of Thromboelastography (TEG) parameters in vascular complications in patients with type 2 diabetes mellitus.
J Diabetes Complications. 2022 Jun 24:108236.
PubMed Abstract available

WU Y, Liu F
Aspartate aminotransferase to alanine aminotransferase ratio and the risk of diabetic nephropathy progression in patients with type 2 diabetes mellitus: A biopsy-based study.
J Diabetes Complications. 2022 Jun 24:108235.
PubMed Abstract available

GUO J, Costacou T, Orchard TJ
Long term risk of heart failure in individuals with childhood-onset type 1 diabetes.
J Diabetes Complications. 2022 Jun 21:108233.
PubMed Abstract available

RIGALLEAU V, Larroumet A, Ducos C, Rigo M, et al
Cardiovascular events after a dramatic reduction of HbA1c in hospitalized subjects with type 2 diabetes and high long-term glucose exposure.
J Diabetes Complications. 2022 Jun 21:108234.
PubMed Abstract available

CHATWIN H, Broadley M, Hendrieckx C, Carlton J, et al
The impact of hypoglycaemia on quality of life among adults with type 1 diabetes: Results from "YourSAY: Hypoglycaemia".
J Diabetes Complications. 2022 Jun 21:108232.
PubMed Abstract available

WUKICH DK, Raspovic KM, Jupiter DC, Heineman N, et al
Amputation and infection are the greatest fears in patients with diabetes foot complications.
J Diabetes Complications. 2022 Jun 10:108222.
PubMed Abstract available

HANDELSMAN Y, Bunch TJ, Rodbard HW, Steinberg BA, et al
Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies.
J Diabetes Complications. 2022 Jun 8:108227. doi: 10.1016/j.jdiacomp.2022.108227
PubMed Abstract available

ALAQEEL A, Gomez R, Chalew SA
Glucose-independent racial disparity in HbA1c is evident at onset of type 1 diabetes.
J Diabetes Complications. 2022 Jun 8:108229. doi: 10.1016/j.jdiacomp.2022.108229
PubMed Abstract available

GUNDOGDU KO, Dogan E, Celik E, Alagoz G, et al
Effect of intravitreal ranibizumab on serous retinal detachment in diabetic macular edema.
J Diabetes Complications. 2022 Jun 7:108228. doi: 10.1016/j.jdiacomp.2022.108228
PubMed

KIBURG KV, Galligan A, Sundararajan V, MacIsaac RJ, et al
Temporal trends in non-traumatic lower extremity amputations (LEAs) and their association with 12-month mortality in people with diabetes, 2004-2016.
J Diabetes Complications. 2022 Jun 3:108221. doi: 10.1016/j.jdiacomp.2022.108221
PubMed Abstract available

SHIMIZU N, Ogawa A, Hayashi A, Shichiri M, et al
Discordance in the reduction rate between glycated albumin and glycated hemoglobin levels in type 2 diabetes patients receiving SGLT2 inhibitors.
J Diabetes Complications. 2022 Jun 2:108225. doi: 10.1016/j.jdiacomp.2022.108225
PubMed Abstract available

MIKOLASEVIC I, Domislovic V, Ruzic A, Hauser G, et al
Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus.
J Diabetes Complications. 2022 Jun 2:108226. doi: 10.1016/j.jdiacomp.2022.108226
PubMed Abstract available

AL-KINDI SG, Janus SE, Neeland IJ, Rajagopalan S, et al
Contemporary utilization of GLP1 receptor agonists and SGLT2 inhibitors in patients with diagnosed type 2 diabetes and cardiovascular disease in the United States.
J Diabetes Complications. 2022 Jun 1:108224. doi: 10.1016/j.jdiacomp.2022.108224
PubMed

May 2022

JOINER KL, McEwen LN, Hurst TE, Adams MP, et al
Domains from the health belief model predict enrollment in the National Diabetes Prevention Program among insured adults with prediabetes.
J Diabetes Complications. 2022 May 17:108220.
PubMed Abstract available

ANG SF, Low SKM, Ng TP, Ang K, et al
Association of early-onset Type 2 diabetes with cognitive impairment is partially mediated by increased pulse pressure.
J Diabetes Complications. 2022 May 13:108209.
PubMed Abstract available

UDDIN J, Zhu S, Malla G, Levitan EB, et al
Trends in diagnosed hypertension prevalence by geographic region for older adults with and without diagnosed diabetes, 2005-2017.
J Diabetes Complications. 2022 May 9:108208. doi: 10.1016/j.jdiacomp.2022.108208
PubMed Abstract available

WENTZELL K, Volkening L, Laffel L
Concordance and discordance between youth and their parents' reports of diabetes distress: The importance of youth perceptions.
J Diabetes Complications. 2022 May 2:108207. doi: 10.1016/j.jdiacomp.2022.108207
PubMed Abstract available

SHAPIRA A, Kane NS, Tanenbaum ML, Hoogendoorn CJ, et al
Memory complaints moderate the concordance between self-report and electronically monitored adherence in adults with type 2 diabetes.
J Diabetes Complications. 2022 May 2:108205. doi: 10.1016/j.jdiacomp.2022.108205
PubMed Abstract available

April 2022

LIMONTE CP, Hall YN, Trikudanathan S, Tuttle KR, et al
Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes.
J Diabetes Complications. 2022 Apr 30:108204.
PubMed Abstract available

MELENA I, Piani F, Tommerdahl KL, Severn C, et al
Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) study.
J Diabetes Complications. 2022 Apr 28:108203.
PubMed Abstract available

SKRHA J JR, Horova E, Soupal J, Valerianova A, et al
Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus.
J Diabetes Complications. 2022 Apr 28:108206.
PubMed Abstract available

CHEN Y, Peng L, He J, Wu J, et al
Impact of hepatitis B virus infection on maternal and infant outcomes of women with gestational diabetes mellitus: A three-year retrospective study.
J Diabetes Complications. 2022 Apr 20:108201.
PubMed Abstract available

OSSAI CI, Wickramasinghe N
A hybrid approach for risk stratification and predictive modelling of 30-days unplanned readmission of comorbid patients with diabetes.
J Diabetes Complications. 2022 Apr 20:108200.
PubMed Abstract available

March 2022

PUNNOSE J, Malhotra RK, Sukhija K, Rijhwani RM, et al
Is HbA1c in the first trimester associated with adverse outcomes among pregnant Asian Indian women without gestational diabetes?
J Diabetes Complications. 2022 Mar 31:108187.
PubMed Abstract available

LOGANATHAN J, Cohen AC, Kaloupis GM, Harris C, et al
A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).
J Diabetes Complications. 2022 Mar 30:108188.
PubMed Abstract available

HUIFEN Z, Yaping X, Meijing Z, Huibin H, et al
Effects of moderate-intensity resistance exercise on blood glucose and pregnancy outcome in patients with gestational diabetes mellitus: A randomized controlled trial.
J Diabetes Complications. 2022 Mar 29:108186.
PubMed Abstract available

VLACHOU E, Ntikoudi A, Owens DA, Nikolakopoulou M, et al
Effectiveness of cognitive behavioral therapy-based interventions on psychological symptoms in adults with type 2 diabetes mellitus: An update review of randomized controlled trials.
J Diabetes Complications. 2022 Mar 26:108185.
PubMed Abstract available

WIUM-ANDERSEN MK, Jorgensen TSH, Jorgensen MB, Rungby J, et al
The association between birth weight, ponderal index, psychotropic medication, and type 2 diabetes in individuals with severe mental illness.
J Diabetes Complications. 2022 Mar 24:108181.
PubMed Abstract available

HOOGENDOORN CJ, Qin J, Wang C, Roque N, et al
Depressive symptoms mediate the relationship between diabetes and cognitive performance in a community-based sample of older adults.
J Diabetes Complications. 2022 Mar 23:108183.
PubMed Abstract available

SARRAY S, Lamine LB, Dallel M, Jairajpuri D, et al
Association of MMP-2 genes variants with diabetic retinopathy in Tunisian population with type 2 diabetes.
J Diabetes Complications. 2022 Mar 18:108182.
PubMed Abstract available

YE W, Ding X, Putnam N, Farej R, et al
Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors.
J Diabetes Complications. 2022 Mar 17:108180.
PubMed Abstract available

IDIAQUEZ RIOS JF, Lovblom LE, Perkins BA, Bril V, et al
Orthostatic blood pressure changes and diabetes duration.
J Diabetes Complications. 2022 Mar 15:108169.
PubMed Abstract available

REN Y, Zhu W, Shi J, Shao A, et al
Association between KCNJ11 E23K polymorphism and the risk of type 2 diabetes mellitus: A global meta-analysis.
J Diabetes Complications. 2022 Mar 11:108170.
PubMed Abstract available

CHUANCHAIYAKUL N, Thongtang N, Rattanaumpawan P
Cumulative incidence of and risk factors for herpes zoster among patients with diabetes mellitus: Results from a 10-year nested case-control study.
J Diabetes Complications. 2022 Mar 8:108168. doi: 10.1016/j.jdiacomp.2022.108168
PubMed Abstract available

SONG XT, Wang SK, Zhang PY, Fan L, et al
Association between epicardial adipose tissue and left ventricular function in type 2 diabetes mellitus: Assessment using two-dimensional speckle tracking echocardiography.
J Diabetes Complications. 2022 Mar 4:108167. doi: 10.1016/j.jdiacomp.2022.108167
PubMed Abstract available

TONG HF, Lee HH, Tong TT, Lam SF, et al
Neurological manifestations in m.3243A>G-related disease triggered by metformin.
J Diabetes Complications. 2022;36:108111.
PubMed Abstract available

February 2022

VAN BAAR MJB, van Bommel EJM, Smits MM, Touw DJ, et al
Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity.
J Diabetes Complications. 2022 Feb 20:108166.
PubMed Abstract available

KARJEE H, Ghosh S, Dhibar T
Association of mid-life cerebral small vessel disease with diabetic retinopathy in type 2 diabetes in an Indian population.
J Diabetes Complications. 2022 Feb 11:108149.
PubMed Abstract available

SIWAN E, Twigg SM, Min D
Alterations of CD163 expression in the complications of diabetes: A systematic review.
J Diabetes Complications. 2022 Feb 9:108150. doi: 10.1016/j.jdiacomp.2022.108150
PubMed Abstract available

GABA R, Balasubramanyam A
Covid-19: A new cause of "provoked" A-beta+ Ketosis-Prone Diabetes.
J Diabetes Complications. 2022 Feb 7:108147. doi: 10.1016/j.jdiacomp.2022.108147
PubMed

MIZOKAMI-STOUT K, Bailey R, Ang L, Aleppo G, et al
Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): Findings from the T1D exchange.
J Diabetes Complications. 2022 Feb 7:108148. doi: 10.1016/j.jdiacomp.2022.108148
PubMed Abstract available

KOCHER T, Holtfreter B, Nauck MA
Comment: Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
J Diabetes Complications. 2022 Feb 5:108146. doi: 10.1016/j.jdiacomp.2022.108146
PubMed

ABDELHAFIZ AH, Sinclair AJ
Metabolic phenotypes explain the relationship between dysglycaemia and frailty in older people with type 2 diabetes.
J Diabetes Complications. 2022 Feb 4:108144. doi: 10.1016/j.jdiacomp.2022.108144
PubMed Abstract available

CROMER SJ, Colling C, Schatoff D, Leary M, et al
Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes.
J Diabetes Complications. 2022 Feb 4:108145. doi: 10.1016/j.jdiacomp.2022.108145
PubMed Abstract available

RASH CJ, Alessi SM, Foster N, Tamborlane W, et al
Tobacco use patterns and clinical outcomes in the T1D exchange.
J Diabetes Complications. 2022;36:108128.
PubMed Abstract available

January 2022

LEWIS EJH, Lovblom LE, Lanctot S, Scarr D, et al
The association between physical activity time and neuropathy in longstanding type 1 diabetes: A cross-sectional analysis of the Canadian study of longevity in type 1 diabetes.
J Diabetes Complications. 2022 Jan 31:108134.
PubMed Abstract available

SHAO H, Kianmehr H, Guo J, Li P, et al
Efficacy of iGlarLixi on 5-year risk of diabetes-related complications: A simulation study.
J Diabetes Complications. 2022 Jan 25:108132.
PubMed Abstract available

RAJALAKSHMI R, UmaSankari G, Sivaprasad S, Venkatesan U, et al
Prevalence and risk factors for diabetic retinopathy in prediabetes in Asian Indians.
J Diabetes Complications. 2022 Jan 23:108131.
PubMed Abstract available

ARAVINDHAN V, Bobhate A, Sathishkumar K, Viswanathan V, et al
Serum levels of novel anti-inflammatory cytokine Interleukin-38 in diabetes patients infected with latent tuberculosis (DM-LTB-3).
J Diabetes Complications. 2022 Jan 22:108133.
PubMed Abstract available

PINCU Y, Tryggestad JB, Teague AM, Short KR, et al
The effect of a high fat meal on heart rate variability and arterial stiffness in adolescents with or without type 1 diabetes.
J Diabetes Complications. 2022 Jan 14:108130.
PubMed Abstract available

ABHINAV RP, Williams J, Bennett C, Livingston P, et al
Frequency and association of self-reported oral cancer among individuals with type 2 diabetes at a tertiary care diabetes centre in South India - A retrospective study.
J Diabetes Complications. 2022 Jan 14:108129.
PubMed Abstract available

CARDOSO CRL, Leite NC, Salles GF
Differential effects of treatment targets on risks of adverse outcomes according to diabetes duration, age and complications: Can these characteristics be used to individualize diabetes treatment? The Rio de Janeiro type 2 diabetes cohort.
J Diabetes Complications. 2022 Jan 13:108124.
PubMed Abstract available

HESP AC, Smits MM, van Bommel EJM, Muskiet MHA, et al
Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes: Analysis of three clinical trials.
J Diabetes Complications. 2022 Jan 11:108127.
PubMed Abstract available

NORGAARD CH, Starkopf L, Gerds TA, Malmborg M, et al
Temporal changes in risk of cardiovascular events in people with newly diagnosed type 2 diabetes with and without cardiovascular disease.
J Diabetes Complications. 2022 Jan 10:108126.
PubMed Abstract available

ABDELAATY T, Morsy E, Rizk M, Shokry A, et al
Relation of serum heart type fatty acid binding protein to left ventricular diastolic dysfunction in patients with type 2 diabetes and early diabetic kidney disease.
J Diabetes Complications. 2022 Jan 4:108122. doi: 10.1016/j.jdiacomp.2021.108122
PubMed Abstract available

STEIGMANN L, Miller R, Trapani VR, Giannobile WV, et al
Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
J Diabetes Complications. 2022 Jan 3:108120. doi: 10.1016/j.jdiacomp.2021.108120
PubMed Abstract available

SHAH RD, Braffett BH, Tryggestad JB, Hughan KS, et al
Cardiovascular risk factor progression in adolescents and young adults with youth-onset type 2 diabetes.
J Diabetes Complications. 2022 Jan 3:108123. doi: 10.1016/j.jdiacomp.2021.108123
PubMed Abstract available

December 2021

BERGENSTAL RM, Mullen DM, Strock E, Johnson ML, et al
Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes.
J Diabetes Complications. 2021 Dec 31:108106.
PubMed Abstract available

MANKOVSKY B
Editorial commentary to manuscript "Neural correlates of slower gait in middle-aged persons with childhood-onset type 1 diabetes mellitus: The impact of accelerated brain aging" by Royse et al.
J Diabetes Complications. 2021 Dec 29:108109.
PubMed

WESTMAN K, Imberg H, Wijkman MO, Hirsch IB, et al
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections.
J Diabetes Complications. 2021 Dec 28:108110.
PubMed Abstract available

CARRASCO-TENEZACA F, Barrera-Guarderas F, De la Torre-Cisneros K, Medina-Escudero M, et al
Time to develop chronic kidney disease in an Ecuadorian Type 2 Diabetes Mellitus cohort: Survival analysis in primary care.
J Diabetes Complications. 2021 Dec 22:108108.
PubMed Abstract available

PARK MS, Jeon J, Song TJ, Kim J, et al
Association of periodontitis with microvascular complications of diabetes mellitus: A nationwide cohort study.
J Diabetes Complications. 2021 Dec 22:108107.
PubMed Abstract available

DOS SANTOS HABER JF, Chagas EFB, Barbalho SM, Sgarbi JA, et al
Level of physical activity and gene expression of IL-10 and TNF-alpha in children and adolescents with Type 1 diabetes.
J Diabetes Complications. 2021 Dec 16:108104.
PubMed Abstract available

SPIERA Z, Ilonzo N, Kaplan H, Leitman IM, et al
Loss of independence as a metric for racial disparities in lower extremity amputation for diabetes: A National Surgery Quality Improvement Program (NSQIP) analysis.
J Diabetes Complications. 2021 Dec 11:108105.
PubMed Abstract available

POLONSKY WH, Fisher L, Hessler D, Desai U, et al
Toward a more comprehensive understanding of the emotional side of type 2 diabetes: A re-envisioning of the assessment of diabetes distress.
J Diabetes Complications. 2021 Dec 10:108103.
PubMed Abstract available

GUPTA RD, Atri A, Mondal S, Bhattacharjee A, et al
Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-beta+ KPD (ketosis-prone diabetes): A prospective study from Eastern India.
J Diabetes Complications. 2021 Dec 9:108100. doi: 10.1016/j.jdiacomp.2021.108100
PubMed Abstract available

HANDELSMAN Y, Anderson JE, Bakris GL, Ballantyne CM, et al
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
J Diabetes Complications. 2021 Dec 7:108101. doi: 10.1016/j.jdiacomp.2021.108101
PubMed Abstract available

POOLE DC
Can exercise training help redress sexual dimorphism in type II diabetes outcomes?
J Diabetes Complications. 2021 Dec 7:108099. doi: 10.1016/j.jdiacomp.2021.108099
PubMed

ZHOU Z, Chen H, Sun M, Jin H, et al
Fetuin-A to adiponectin ratio is an independent indicator of subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes mellitus.
J Diabetes Complications. 2021 Dec 3:108102. doi: 10.1016/j.jdiacomp.2021.108102
PubMed Abstract available

SIDHU G, Samson R, Nedunchezian SH, Srivastav S, et al
COVID 19 in-hospital mortality, body mass index and obesity related conditions.
J Diabetes Complications. 2021;35:108054.
PubMed Abstract available

HUANG W, Whitelaw J, Kishore K, Neto AS, et al
The comparative epidemiology and outcomes of hospitalized patients treated with SGLT2 or DPP4 inhibitors.
J Diabetes Complications. 2021;35:108052.
PubMed Abstract available

November 2021

GREEN S, Kiely C, O'Connor E, Gildea N, et al
Differential effects of sex on adaptive responses of skeletal muscle vasodilation to exercise training in type 2 diabetes.
J Diabetes Complications. 2021 Nov 29:108098.
PubMed Abstract available

ZHUO X, Melzer Cohen C, Chen J, Chodick G, et al
Validating the UK prospective diabetes study outcome model 2 using data of 94,946 Israeli patients with type 2 diabetes.
J Diabetes Complications. 2021 Nov 14:108086.
PubMed Abstract available

ROYSE SK, Costacou T, Nunley KA, Orchard TJ, et al
Neural correlates of slower gait in middle-aged persons with childhood-onset type 1 diabetes mellitus: The impact of accelerated brain aging.
J Diabetes Complications. 2021 Nov 14:108084.
PubMed Abstract available

NATTERO-CHAVEZ L, Martinez-Garcia MA, Redondo Lopez S, Fernandez-Duran E, et al
High serum copeptin may be a marker of an increased carotid intima-media thickness in asymptomatic patients with type 1 diabetes.
J Diabetes Complications. 2021 Nov 11:108085.
PubMed Abstract available

VALENTE F, Valente T, Crispim F, Bittencourt CS, et al
Parents' cardiovascular risk factors are related to overweight and obesity in young Brazilians with type 1 diabetes.
J Diabetes Complications. 2021 Nov 5:108082. doi: 10.1016/j.jdiacomp.2021.108082
PubMed Abstract available

HU X, Yu W, Yang L, Pan W, et al
First-degree family history of diabetes is associated with nonalcoholic fatty liver disease independent of glucose metabolic status.
J Diabetes Complications. 2021 Nov 4:108083. doi: 10.1016/j.jdiacomp.2021.108083
PubMed Abstract available

KOHZUMA T, Tao X, Koga M
Glycated albumin as biomarker: Evidence and its outcomes.
J Diabetes Complications. 2021;35:108040.
PubMed Abstract available

TERZO S, Amato A, Mule F
From obesity to Alzheimer's disease through insulin resistance.
J Diabetes Complications. 2021;35:108026.
PubMed Abstract available

KIM YH, Her AY, Jeong MH, Kim BK, et al
Comparison of two-year clinical outcomes according to glycemic status and renal function in patients with acute myocardial infarction following implantation of new-generation drug-eluting stents.
J Diabetes Complications. 2021;35:108019.
PubMed Abstract available

October 2021

GAEBE K, White CA, Mahmud FH, Scholey JW, et al
Evaluation of novel glomerular filtration rate estimation equations in adolescents and young adults with type 1 diabetes.
J Diabetes Complications. 2021 Oct 29:108081.
PubMed Abstract available

MORIYA T, Hayashi A, Matsubara M, Suzuki A, et al
Glucose control, diabetic retinopathy, and hemodialysis induction in subjects with normo-microalbuminuric type 2 diabetic patients with normal renal function followed for 15 years.
J Diabetes Complications. 2021 Oct 29:108080.
PubMed Abstract available

SAMANTH J, Padmakumar R, Vasudeva A, Lewis L, et al
Persistent subclinical myocardial dysfunction among infants of diabetic mothers.
J Diabetes Complications. 2021 Oct 21:108079.
PubMed Abstract available

OZUYNUK AS, Erkan AF, Dogan N, Ekici B, et al
Examining the effects of the CLU and APOE polymorphisms' combination on coronary artery disease complexed with type 2 diabetes mellitus.
J Diabetes Complications. 2021 Oct 15:108078.
PubMed Abstract available

KHUNTI K, Heerspink HJL, Lam CSP, Nicolucci A, et al
Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities.
J Diabetes Complications. 2021 Oct 13:108077.
PubMed Abstract available

SEAH JM, Botterill E, MacIsaac RJ, Milne M, et al
Functional MRI in assessment of diabetic kidney disease in people with type 1 diabetes.
J Diabetes Complications. 2021 Oct 12:108076.
PubMed Abstract available

KATSIKI N, Fonseca V
Stroke prevention in diabetes with glucagon-like peptide-1 receptor agonists: A game-changer?
J Diabetes Complications. 2021 Oct 9:108075. doi: 10.1016/j.jdiacomp.2021.108075
PubMed

SALNA I, Salna E, Pahirko L, Skrebinska S, et al
Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes.
J Diabetes Complications. 2021 Oct 8:108072. doi: 10.1016/j.jdiacomp.2021.108072
PubMed Abstract available

GUNES M, Temizkan S, Apaydin T, Ilgin C, et al
Serum osteoprotegerin levels, endothelial function and carotid intima-media thickness in type 2 diabetic patients.
J Diabetes Complications. 2021 Oct 8:108073. doi: 10.1016/j.jdiacomp.2021.108073
PubMed Abstract available

UMAPATHY D, Subramanyam PV, Krishnamoorthy E, Viswanathan V, et al
Association of Fetuin-A with Thr256Ser exon polymorphism of alpha2-Heremans Schmid Glycoprotein (AHSG) gene in type 2 diabetic patients with overt nephropathy.
J Diabetes Complications. 2021 Oct 8:108074. doi: 10.1016/j.jdiacomp.2021.108074
PubMed Abstract available

WANG BK, Wukich DK, Sambandam S
Complications from ankle arthrodesis in diabetes-related Charcot foot syndrome.
J Diabetes Complications. 2021 Oct 6:108071. doi: 10.1016/j.jdiacomp.2021.108071
PubMed Abstract available

ZHANG X, Zhou Y, Ma R
Potential effects and application prospect of angiotensin receptor-neprilysin inhibitor in diabetic kidney disease.
J Diabetes Complications. 2021 Oct 6:108056. doi: 10.1016/j.jdiacomp.2021.108056
PubMed Abstract available

XU Y, Shan X, Wang H
A nomogram for predicting the risk of new-onset albuminuria based on baseline urinary ACR, orosomucoid, and HbA1c in patients with type 2 diabetes.
J Diabetes Complications. 2021 Oct 5:108058. doi: 10.1016/j.jdiacomp.2021.108058
PubMed Abstract available

TSILINGIRIS D, Makrilakis K, Barmpagianni A, Dalamaga M, et al
The glycemic status determines the direction of the relationship between red cell distribution width and HbA1c.
J Diabetes Complications. 2021;35:108012.
PubMed Abstract available

September 2021

KANNENKERIL D, Jung S, Harazny J, Striepe K, et al
Tissue sodium content correlates with hypertrophic vascular remodeling in type 2 diabetes.
J Diabetes Complications. 2021 Sep 29:108055.
PubMed Abstract available

HITCHEN SA, Lan NSR, Rankin JM, Larbalestier R, et al
Real-world barriers and safety of initiating sodium-glucose co-transporter 2 inhibitor treatment immediately following an acute cardiac event in people with diabetes.
J Diabetes Complications. 2021 Sep 29:108057.
PubMed Abstract available

SILVEIRA MSVM, Pavin EJ, Cardoso EB, Fanti P, et al
Emotional burden and care of adults with type 1 diabetes during the COVID-19 pandemic in Brazilian regions.
J Diabetes Complications. 2021 Sep 28:108053.
PubMed Abstract available

PRADEEPA R, Subashini R, Venkatesan U, Ningombam S, et al
Effect of internal migration on diabetes and metabolic abnormalities in India - The ICMR-INDIAB study.
J Diabetes Complications. 2021 Sep 25:108051.
PubMed Abstract available

CHEN N, Song S, Yang Z, Wu M, et al
ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy.
J Diabetes Complications. 2021 Sep 23:108050.
PubMed Abstract available

FAULKNER MS, Smart MJ
Sleep quality and heart rate variability in adolescents with type 1 or type 2 diabetes.
J Diabetes Complications. 2021 Sep 22:108049.
PubMed Abstract available

LIU J, Li J, Li W, Li N, et al
Predictive values of serum metabolites in early pregnancy and their possible pathways for gestational diabetes: A nested case-control study in Tianjin, China.
J Diabetes Complications. 2021 Sep 21:108048.
PubMed Abstract available

SAELY CH, Maechler M, Vonbank A, Sprenger L, et al
Single and joint impact of type 2 diabetes and of congestive heart failure on albuminuria.
J Diabetes Complications. 2021 Sep 12:108046.
PubMed Abstract available

CAI X, Lin C, Yang W, Dagogo-Jack S, et al
Cardiovascular outcomes of antidiabetes medications by race/ethnicity: A systematic review and meta-analysis.
J Diabetes Complications. 2021;35:107980.
PubMed Abstract available

August 2021

GOPI S, Gowri P, Panda JK, Sathyanarayana SO, et al
Insulin gene mutations linked to permanent neonatal diabetes mellitus in Indian population.
J Diabetes Complications. 2021 Aug 17:108022.
PubMed Abstract available

SAKAI T, Aoyama K, Inazumi K, Kikuchi R, et al
Time in range correlates glycated albumin measured immediately after 2weeks of continuous glucose monitoring.
J Diabetes Complications. 2021;35:107962.
PubMed Abstract available

RAO C, Ping F
Second-trimester maternal lipid profiles rather than glucose levels predict the occurrence of neonatal macrosomia regardless of glucose tolerance status: A matched cohort study in Beijing.
J Diabetes Complications. 2021;35:107948.
PubMed Abstract available

ZHANG Y, Sun J, Liu L, Qiao H, et al
A review of biosensor technology and algorithms for glucose monitoring.
J Diabetes Complications. 2021;35:107929.
PubMed Abstract available

July 2021

MOSTAFA TM, Hegazy SK, Elnaidany SS, Shehabeldin WA, et al
Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: A comparative study of Nigella sativa versus both lifestyle modification and metformin.
J Diabetes Complications. 2021;35:107947.
PubMed Abstract available

SONG XT, Fan L, Yan ZN, Rui YF, et al
Echocardiographic evaluation of the effect of poor blood glucose control on left ventricular function and ascending aorta elasticity.
J Diabetes Complications. 2021;35:107943.
PubMed Abstract available

April 2021

WIKSTROM J, Liu Y, Whatling C, Gan LM, et al
Diastolic dysfunction and impaired cardiac output reserve in dysmetabolic nonhuman primate with proteinuria.
J Diabetes Complications. 2021;35:107881.
PubMed Abstract available

ANDERSON J, Meneghini L, Hinnen D, Gill J, et al
Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control.
J Diabetes Complications. 2021;35:107831.
PubMed Abstract available

March 2021

GARLA V, Subauste A, Butler J, Lien LF, et al
The role of sodium glucose co-transporter inhibitors in heart failure prevention.
J Diabetes Complications. 2021;35:107811.
PubMed Abstract available

LUO D, Shi Y, Zhu M, Wang H, et al
Subclinical lipohypertrophy--Easily ignored complications of insulin therapy.
J Diabetes Complications. 2021;35:107806.
PubMed Abstract available

JIALAL I, Patel A, Devaraj S, Adams-Huet B, et al
Metabolites that activate the inflammasome in nascent metabolic syndrome.
J Diabetes Complications. 2021;35:107836.
PubMed Abstract available

BLAIR HR, Tomas C, Miwa S, Heath A, et al
Peroxisomes and pancreatic beta-cell lipo-dysfunction.
J Diabetes Complications. 2021;35:107843.
PubMed Abstract available

February 2021

QIU M, Ding LL, Zhang M, Zhou HR, et al
Comparison of the risk of SGLT2is and NonSGLT2is in leading to amputation: A network meta-analysis.
J Diabetes Complications. 2021;35:107803.
PubMed Abstract available

LILJA E, Gottsater A, Miftaraj M, Ekelund J, et al
The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis.
J Diabetes Complications. 2021;35:107675.
PubMed Abstract available

January 2021

KIM W, Go T, Kang DR, Lee EJ, et al
Hemoglobin glycation index is associated with incident chronic kidney disease in subjects with impaired glucose metabolism: A 10-year longitudinal cohort study.
J Diabetes Complications. 2021;35:107760.
PubMed Abstract available

AARTHY R, Aston-Mourney K, Mikocka-Walus A, Radha V, et al
Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - A review.
J Diabetes Complications. 2021;35:107640.
PubMed Abstract available

HIRSCH IB, Gaudiani LM
A new look at brittle diabetes.
J Diabetes Complications. 2021;35:107646.
PubMed Abstract available

KUMARAN S, Unnikrishnan AG
Fibrocalculous pancreatic diabetes.
J Diabetes Complications. 2021;35:107627.
PubMed Abstract available

STONE SI, Abreu D, McGill JB, Urano F, et al
Monogenic and syndromic diabetes due to endoplasmic reticulum stress.
J Diabetes Complications. 2021;35:107618.
PubMed Abstract available

YEUNG RO, Al Jundi M, Gubbi S, Bompu ME, et al
Management of mitochondrial diabetes in the era of novel therapies.
J Diabetes Complications. 2021;35:107584.
PubMed Abstract available

December 2020

IIDA M, Ishiguro Y
Association of prediabetes with impaired left atrial contractility in patients with never-treated hypertension.
J Diabetes Complications. 2020 Dec 31:107827.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.